Noelia Solis Ramirez
Family · Irving, TXNPI 1841807203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 26.9% of the total. Reporting peaked in 2022 at $915 and has fallen 96.1% since, to $36 in 2024.
Across 98 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$464
- Novo Nordisk$213
- Lilly USA, LLC$132
- Mannkind Corporation$129
- Boehringer Ingelheim$120
- Johnson & Johnson$100
- plus $564 from 13 others
What the payments were for
- Food & beverage$1,722100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $464 |
| Novo Nordisk | 17 | $213 |
| Lilly USA, LLC | 9 | $132 |
| Mannkind Corporation | 2 | $129 |
| Boehringer Ingelheim | 5 | $120 |
| Johnson & Johnson | 2 | $100 |
| Bayer | 4 | $75 |
| Redhill Biopharma Inc. | 4 | $72 |
| Sanofi Pasteur Inc. | 3 | $63 |
| Merck | 4 | $62 |
| Medtronic | 4 | $56 |
| Pfizer | 3 | $51 |
| Cranial Technologies, Inc | 2 | $43 |
| AstraZeneca | 2 | $34 |
| Vivus LLC | 2 | $33 |
| Exact Sciences | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| GSK | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFREZZA$114
How this compares
$1,722 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 19 | $122 |
| Metformin Hcl | 15 | $64 |
| Lisinopril | 13 | $49 |
| Amlodipine Besylate | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other family in Irving
- Susan BowlinIrving$164K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.